OCGN FY 2020 Earnings — Ocugen, Inc. Revenue & Financial Results | Market Cap Arena

OCGNOcugen, Inc.

$578M

FY 2020 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$43,000

Gross Profit

-$6M-14676.7% margin

Operating Income

-$21M-49500.0% margin

Net Income

-$22M-50748.8% margin

EPS (Diluted)

$-0.31

Cash Flow

Operating Cash Flow

-$15M

Free Cash Flow

-$15M

Stock-Based Comp.

$660,000

Balance Sheet

Total Assets

$27M

Total Liabilities

$6M

Stockholders' Equity

$22M

Cash & Equivalents

$24M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$43,000	$0	—
Gross Profit	-$6M	-$8M	+22.0%
Operating Income	-$21M	-$14M	-50.3%
Net Income	-$22M	-$20M	-7.8%